News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Infectious Diseases. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
01.31.2023Northwestern University professors Luisa Iruela-Arispe, PhD, Murali Prakriya, PhD, Linda A. Teplin, PhD and Teri W. Odom, PhD, have been selected as 2022 fellows of the American Association for the Advancement of Science (AAAS), the largest general scientific society in the world.
12.07.2022Feinberg’s Robert J. Havey, MD Institute for Global Health hosted the 11th annual Global Health symposium on December 2, celebrating global health research, education and outreach efforts from Feinberg global health investigators, faculty, students and community partners.
11.28.2022Northwestern Medicine investigators continue to study the impact of the COVID-19 pandemic on health outcomes and society, from maternal vaccinations and antibody response to reducing burnout amongst healthcare workers and identifying novel therapeutic targets.
09.15.2022Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.
09.07.2022Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.
07.28.2022Northwestern Medicine scientists are expanding the global network of COVID-19 sequencing in regions where there is limited viral genetic information reporting.
06.07.2022Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
05.26.2022Feinberg’s Medical Faculty Council recently honored the recipients of the 2022 Mentor of the Year award at a virtual mentoring workshop.
04.20.2022In this feature story, Northwestern scientists share their work at the forefront of HIV research, pioneering new strategies to investigate, treat, and work towards a cure for the disease.
04.12.2022New advances in CRISPR gene-editing technology may lead to longer-lasting treatments and new therapeutic strategies for HIV/AIDS.
03.28.2022Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
03.10.2022Frank Palella, MD, is working towards increasing the lifespan and “healthspan” of people living with HIV through research, education and patient care as director of the new Potocsnak Center for Aging and HIV.
02.21.2022Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
02.18.2022A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
- 02.14.2022
Medical students performed comedy skits and musical numbers that satirized the medical school experience at In Vivo, Feinberg’s annual sketch comedy and variety show.
02.04.2022Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
02.03.2022A recent Northwestern Medicine study found global efforts to track variants grossly underreported a probable variant of concern, Eta, circulating in Nigeria in early 2021.
- 01.21.2022
A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
12.27.2021Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.
12.08.2021Feinberg’s Robert J. Havey, MD Institute for Global Health hosted the 10th annual Global Health Day symposium on December 3, featuring keynote speakers, online poster presentations, and question and answers sessions.
- 11.30.2021
Northwestern Medicine scientists continue to tackle every facet of the COVID-19 pandemic, from investigating coronavirus vaccines’ potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.
10.28.2021Through the Robert J. Havey, MD Institute for Global Health, Feinberg faculty across disciplines are training investigators from Africa, many of whom are enrolled in Feinberg graduate programs, on how to effectively conduct research about diseases currently impacting their home countries.
- 10.28.2021
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
09.22.2021Northwestern University Trustees and alumni Patrick G. Ryan and Shirley W. Ryan have made a historic gift to name and endow the Robert J. Havey, MD Institute for Global Health.
- 08.27.2021
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
06.23.2021The Northwestern Medicine Comprehensive COVID-19 Center is committed to caring for and conducting research on behalf of patients who experience long-term complications from COVID-19.
- 06.07.2021
Northwestern Medicine investigators continue to assess COVID-19 treatments for mild to severe cases, the widespread adoption of telemedicine, and why a “return to normal” will be a missed opportunity to improve healthcare.
05.05.2021The Institute for Global Health (IGH) has established the Center for Pathogen Genomics and Microbial Evolution which will apply lessons learned during the COVID-19 pandemic to the tracking and prevention of future threats.
04.02.2021It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.